Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Jan 4;16:9–21. doi: 10.2147/JAA.S375325

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2023 Portel et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

Exacerbations and treatment control (ACT score) according to the cut-off value for blood eosinophil count. (1) EOS- group included patients with EOS <300 G/l and EOS+ group included patients with EOS count >300 G/l; (2) EOS- group included patients with EOS count <150 G/l and EOS+ included patients with EOS count >150 G/l.

Notes: Only patients with severe asthma were included in the study. Exacerbations were defined based on oral corticosteroids (OCS) use or increased dose of inhaled corticosteroids (ICS).

Abbreviations: ACT, Asthma Control Test; EOS, Blood eosinophil cell; G/l, Giga per liter; N, Number of patients.